Annexon, Inc. (ANNX) stock
ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.92−0.05 (-1.26%)
Close on Nov 13, 2026Market cap $801.42MP/E –Yield 0.00%
Annexon enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Annexon's enterprise value was $544.15M on Nov 11, 2026, against $488.92M a year earlier. Over the last 5 years it ranged from -$144.37M to $750.94M, with a median of $112.05M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $544.15M | -4.1% |
| 2025 | Dec 31, 2025 | $567.23M | +114.9% |
| 2024 | Dec 31, 2024 | $263.94M | +53.6% |
| 2023 | Dec 29, 2023 | $171.78M | – |
| 2022 | Dec 30, 2022 | -$31.32M | -107.7% |
| 2021 | Apr 30, 2021 | $409.28M | -30.0% |
| 2020 | Dec 31, 2020 | $584.40M | – |
See a number that looks wrong?